Kalbe Farma Tbk PT (KLBF) - Total Liabilities

Latest as of June 2025: Rp5.32 Trillion IDR ≈ $311.65 Million USD

Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has total liabilities worth Rp5.32 Trillion IDR (≈ $311.65 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Kalbe Farma Tbk PT net asset momentum to track the company's year-over-year net asset growth rate.

Kalbe Farma Tbk PT - Total Liabilities Trend (2000–2024)

This chart illustrates how Kalbe Farma Tbk PT's total liabilities have evolved over time, based on quarterly financial data. See Kalbe Farma Tbk PT (KLBF) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Kalbe Farma Tbk PT Competitors by Total Liabilities

The table below lists competitors of Kalbe Farma Tbk PT ranked by their total liabilities.

Company	Country	Total Liabilities
Anhui Jiangnan Chemical Industry Co Ltd SHE:002226	China	CN¥10.88 Billion
Shanghai Suochen Information Technology Co. Ltd. A SHG:688507	China	CN¥545.11 Million
SIMMTECH Co. Ltd KQ:222800	Korea	₩1.01 Trillion
Flight Centre Travel Group Ltd AU:FLT	Australia	AU$3.47 Billion
Sino Horizon Holdings Ltd TW:2923	Taiwan	NT$70.89 Billion
Vimian Group AB ST:VIMIAN	Sweden	Skr401.00 Million
Forvia SE PA:FRVIA	France	€22.73 Billion
Shaanxi Huaqin Technology Industry Co. Ltd. A SHG:688281	China	CN¥1.66 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Kalbe Farma Tbk PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kalbe Farma Tbk PT (KLBF) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.37	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kalbe Farma Tbk PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kalbe Farma Tbk PT (2000–2024)

The table below shows the annual total liabilities of Kalbe Farma Tbk PT from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	Rp4.84 Trillion ≈ $283.56 Million	+22.90%
2023-12-31	Rp3.94 Trillion ≈ $230.72 Million	-23.45%
2022-12-31	Rp5.14 Trillion ≈ $301.42 Million	+16.89%
2021-12-31	Rp4.40 Trillion ≈ $257.87 Million	+2.62%
2020-12-31	Rp4.29 Trillion ≈ $251.27 Million	+20.48%
2019-12-31	Rp3.56 Trillion ≈ $208.55 Million	+24.81%
2018-12-31	Rp2.85 Trillion ≈ $167.09 Million	+4.75%
2017-12-31	Rp2.72 Trillion ≈ $159.51 Million	-1.45%
2016-12-31	Rp2.76 Trillion ≈ $161.85 Million	+0.15%
2015-12-31	Rp2.76 Trillion ≈ $161.62 Million	+5.77%
2014-12-31	Rp2.61 Trillion ≈ $152.79 Million	-7.37%
2013-12-31	Rp2.82 Trillion ≈ $164.95 Million	+37.57%
2012-12-31	Rp2.05 Trillion ≈ $119.91 Million	+16.36%
2011-12-31	Rp1.76 Trillion ≈ $103.05 Million	+39.51%
2010-12-31	Rp1.26 Trillion ≈ $73.86 Million	-25.49%
2009-12-31	Rp1.69 Trillion ≈ $99.13 Million	+24.46%
2008-12-31	Rp1.36 Trillion ≈ $79.65 Million	+21.20%
2007-12-31	Rp1.12 Trillion ≈ $65.72 Million	+3.79%
2006-12-31	Rp1.08 Trillion ≈ $63.32 Million	-40.69%
2005-12-31	Rp1.82 Trillion ≈ $106.76 Million	+18.51%
2004-12-31	Rp1.54 Trillion ≈ $90.08 Million	+7.89%
2003-12-31	Rp1.42 Trillion ≈ $83.49 Million	+4.45%
2002-12-31	Rp1.36 Trillion ≈ $79.93 Million	-10.92%
2001-12-31	Rp1.53 Trillion ≈ $89.73 Million	+5.46%
2000-12-31	Rp1.45 Trillion ≈ $85.09 Million	--

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General

Market Cap

$1.93 Billion

Rp32.85 Trillion IDR

Market Cap Rank

#6190 Global

#51 in Indonesia

Share Price

Rp725.00

Change (1 day)

+4.32%

52-Week Range

Rp665.00 - Rp1435.00

All Time High

Rp2271.54